Trioxsalen derivatives with lipoxygenase inhibitory activity

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 6, 2009, Pages 1351-1356

  Hadjipavlou Litina, D ^a   Bariamis, S E ^b   Militsopoulou, M ^b   Athanassopoulos, C M ^b   Papaioannou, D ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Anti inflammatory activities; Antioxidant activities; Lipid peroxidation; Lipoxygenase inhibitors; Psoralens; Trioxsalen; Trioxsalen derivatives

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; BUTYLCRESOL; CARRAGEENAN; HYDROXAMIC ACID; INDOMETACIN; LIPOXYGENASE; N HYDROXY 3 (TRIOXSALEN 4' YL)ACRYLAMIDE; N TERT BUTOXY 3 (TRIOXSALEN 4' YL)ACRYLAMIDE; PSORALEN; PSORALEN DERIVATIVE; TRIOXYSALEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IC 50; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; RING OPENING; SCAVENGING SYSTEM; SOYBEAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CARRAGEENAN; EDEMA; FEMALE; FREE RADICAL SCAVENGERS; HINDLIMB; INDOMETHACIN; INFLAMMATION; INHIBITORY CONCENTRATION 50; LIPID PEROXIDATION; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; MALE; PICRATES; RATS; SOYBEANS; TRIOXSALEN;

GLYCINE MAX; RATTUS;

EID: 73949147929     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756360902932776     Document Type: Article

References (28)

1. Bonish B, Jullien D, Dutronc Y, Bei Huang B, Modlin R, Spada FM, et al. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-? production by NK-T cells. J Immunol 2000;165:4076-4085
2. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568-572
3. Nakano H, Inoue T, Kawasaki N, Miyataka H, Matsumoto H, Taguchi T, et al. Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action. Bioorg Med Chem 2000;8:373-380
4. Hussain H, Shornick LP, Shannon VR, Wilson JD, Funk CD, Pentland AP, et al. Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis. J Am J Physiol 1994;266:C243-53.
5. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2000;20:2100-2105
6. Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, et al. Lipoxygenase inhibitors as potential cancer chemopreventives. J Cancer Epidemiol Biomark Prev 1999;8:467-483
7. Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, et al. Fivelipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 2001;15:2007-2009
8. Gia O, Magno SM, Gonzalez-Diaz H, Quezada E, Santana L, Uriarte E, et al. Design, synthesis and photobiological properties of 3,4- cyclopentenepsoralens. Bioorg Med Chem 2005;13:809-817 and references cited therein.
9. Leite VC, Santos RF, Chen LC, Guillo LA. Psoralen derivatives and longwave ultraviolet irradiation are active in vitro against human melanoma cell line. J Photochem Photobiol 2004;76:49-53 and references cited therein.
10. van der Kerkhof PCM. The management of psoriasis. Neth J Med 1998;52:40-45 and references cited therein.
11. Militsopoulou M, Bariamis SE, Athanassopoulos CM, Papaioannou D. Synthetic studies towards the development of psoralen-acidic retinoid conjugates and hybrids. Synthesis 2008;(21):3433-3442
12. Pilkington T, Brogden RN. Acitretin. A review of its pharmacology and therapeutic use. Drugs 1992;43:597-627.
13. Kim JS, Kim JC, Shim SH, Lee EJ, Jin W, Bae K, et al. Chemical constituents of the root of Dystaenia takeshimana and their anti-inflammatory activity. Arch Pharmacol Res 2006;29:617-623
14. Kontogiorgis C, Hadjipavlou-Litina D. Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory/ antioxidants agents. J Enzyme Inhib Med Chem 2003;18:63-69
15. Biobyte Corp., C-QSAR Database, 201 West 4th Str., Suite 204, Claremont CA, California 91711, USA.
16. Liegois C, Lermusieau G, Colin S. Measuring antioxidant efficiency of wort, malt, and hops against the 2,2-azobis(2-amidinopropane) dihydrochloride-induced oxidation of an aqueous dispersion of linoleic acid. J Agric Food Chem 2000;48:1129-1134
17. Gavalas A, Kourounakis A, Litina D, Kourounakis P. Anti-inflammatory and Immunomodulating effects of the novel agent ?-(2-aminoethylamino)- 2-butyrothienone. Arzneimittelforschung 1991;41:423-426
18. Flohe L, Beckman R, Giertz H, Loschen G. Oxygen-centered free radicals as mediators of inflammation. In: Sies H, ed. Oxidative Stress. London: Academic Press, 1985:403-435
19. Saldanha LA, Elias G, Gao MNA. Oxygen radical scavenging activity of phenylbutenones and their correlation with antiinflammatory activity. Arzneimittelforschung 1990;40:89-91.
20. Prior RL, Wu X, Schaich K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem 2005;53:4290-4303
21. Kulisic T, Radonic A, Katalinic V, Milos M. Use of different methods for testing antioxidative activity of oregano essential oil. Food Chem 2004;85:633-640
22. Molyneux P. The use of the stable free radical diphenylpicryl-hydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J Sci Technol 2004;26:211-219
23. Koleva II, van Beek TA, Linssen JPH, de Groot A, Evstatieva LN. Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochem Anal 2001;13:8-17.
24. Kuhn H, Belkner J, Wiesner R, Brash AR. Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J Biol Chem 1990;265:18351-18361
25. Taraporewala RB, Kauffman JM. Synthesis and structure activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridinealkanoic acids and 4-(2-carboxyphenyl)aminobenzenealkanoic acids. J Pharm Sci 1990;79:173-178
26. Muller K. 5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs. Arch Pharm (Weinheim) 1994;327:3-19.
27. Pontiki E, Hadjipavlou-Litina D. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs. Med Res Rev 2008;28:39-117.
28. Shen TY. Non steroidal anti-inflammatory agents. In: Wolf ME, ed. Burger's Medicinal Chemistry. New York: John Wiley and Sons, 1980:1217-1219